EXAI
  
  
      
        Exscientia Plc American Depositary Shares
      
      
        
          EXAI
        
        
      
    
  
          EXAI
        
        
      Delisted
    EXAI was delisted on the 19th of November, 2024.
About: Exscientia PLC is engaged in the application of artificial intelligence (AI) and machine learning (ML) to the discovery and design of novel therapeutic compounds. The company's technology platform combines human and computational capabilities to accelerate the process of designing novel, safe, and efficacious compounds for clinical testing in humans. The company is focused on the discovery and development of small-molecule drug candidates.
Employees: 483
      Price charts implemented using
      
        Lightweight Charts™